Key statistics dashboard for Veracyte, Inc. (VCYT). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis.
Stock Data
| Price | $47.67 |
| Market Cap | $3.8B |
| Enterprise Value | $3.54B |
| Beta | 1.96 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | 33.10 |
| Price / Book | 2.73 |
| P/S | 6.77 |
| EV/EBITDA | 27.31 |
| EV/Sales | 6.31 |
| EV/FCF | 21.42 |
| P/FCF | 22.99 |
| Earnings Yield | 3.01% |
| FCF Yield | 4.35% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 72.09% |
| EBIT Margin | 19.39% |
| EBITDA Margin | 23.10% |
| Operating Margin | 17.03% |
| Net Margin | 20.37% |
| Return on Equity | 8.64% |
| Return on Assets | 7.70% |
| Return on Invested Capital | 6.70% |
| Return on Capital Employed | 6.72% |
Financial Health
| Current Ratio | 9.16 |
| Quick Ratio | 8.80 |
| Cash Ratio | 4.77 |
| Debt / Equity | 0.03 |
| Debt / Assets | 2.70% |
| Net Debt / EBITDA | -2.00 |
| Interest Coverage | 0.00 |
| Piotroski F-Score | 7 |
| Altman Z-Score | 21.11 |
Per-Share Data
| Revenue per share | 7.05 |
| Book Value per share | 17.43 |
| Cash per share | 6.09 |
| FCF per share | 2.08 |
| Tangible Book Value per share | 6.76 |
| Dividend per share | 0.00 |
Related companies: ADPT · IDYA · IRON · KNSA · LEGN
Explore sector: Healthcare · Medical - Diagnostics & Research
More sections of VCYT: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks